Journal
REGENERATIVE THERAPY
Volume 8, Issue -, Pages 20-28Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.reth.2017.12.001
Keywords
Anterior cruciate ligament; Bone marrow; Mesenchymal stem/stromal cell; Cell surface marker; Differentiation; Regeneration therapy
Categories
Funding
- Japan Agency for Medical Research and Development (AMED) [15bk0104037h0002]
- Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan [17K01753, 15K06853, 16K19191]
- Grants-in-Aid for Scientific Research [17K01753, 15K06853, 16K19191] Funding Source: KAKEN
Ask authors/readers for more resources
Introduction: The anterior cruciate ligament (ACL) consists of various components, such as collagen, elastin fibres, and fibroblasts. Because ACL has a poor regenerative ability, ACL reconstruction need require the use of autologous tendons. In recent years, tissue-resident stem cells have been studied to promote ACL regeneration as an alternatively method. However, the existence of stem cells in ligaments has not been clearly defined. Here, we prospectively isolated stem cells from ACLs and characterized their properties. Methods: ACLs from 11 donors and bone marrows (BM) from 8 donors were obtained with total knee arthroplasty. We used flow cytometry to screen the cell surface markers on ACL cells. Frozen sections were prepared from patient ACL tissues and stained with specific antibodies. Cultured ACL-derived and BM-derived cells at passage 3 were differentiated into adipocytes, osteoblasts and tendon/ligament cells. Results: ACL-derived mesenchymal stem/stromal cells (ACL-MSCs) expressed high levels of CD73 and CD90. Immunohistochemical analyses revealed that ACL-MSCs were located on the inner surface of ACL sinusoids. Furthermore, the expression of cell surface antigens was clearly different between ACL-MSCs and bone marrow (BM)-derived MSCs (BM-MSCs) at the time of isolation, but the two cell populations became indistinguishable after long-term culture. Interestingly, ACL-MSCs are markedly different from BM-MSCs in their differentiation ability and have a high propensity to differentiate into ligament-committed cells. Conclusions: Our findings suggest that ACL-MSCs express CD90 and CD73 markers, and their differentiation capacity is maintained even through culture. The cell population having tissue-specific properties is an important research target for investigating the ligament therapies. (C) 2018, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available